Authors: Cockerill, S Stubberfield, C Stables, J Carter, M Guntrip, S Smith, K McKeown, S Shaw, R Topley, P Thomsen, L Affleck, K Jowett, A Hayes, D Willson, M Woollard, P Spalding, D

Citation: S. Cockerill et al., Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and C-erbB-2, BIOORG MED, 11(11), 2001, pp. 1401-1405

Authors: Bain, JM Stubberfield, C Gow, NAR

Citation: Jm. Bain et al., Ura-status-dependent adhesion of Candida albicans mutants, FEMS MICROB, 204(2), 2001, pp. 323-328

Authors: Rusnak, DW Affleck, K Cockerill, SG Stubberfield, C Harris, R Page, M Smith, KJ Guntrip, SB Carter, MC Shaw, RJ Jowett, A Stables, J Topley, P Wood, ER Brignola, PS Kadwell, SH Reep, BR Mullin, RJ Alligood, KJ Keith, BR Crosby, RM Murray, DM Knight, WB Gilmer, TM Lackey, K

Citation: Dw. Rusnak et al., The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancer, CANCER RES, 61(19), 2001, pp. 7196-7203

Authors: McKenzie, E Tyson, K Stamps, A Smith, P Turner, P Barry, R Hircock, M Patel, S Barry, E Stubberfield, C Terrett, J Page, M

Citation: E. Mckenzie et al., Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member, BIOC BIOP R, 276(3), 2000, pp. 1170-1177

Authors: Page, MJ Amess, B Rohlff, C Stubberfield, C Parekh, R

Citation: Mj. Page et al., Proteomics: a major new technology for the drug discovery process, DRUG DISC T, 4(2), 1999, pp. 55-62